ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia

Sunil K. Joshi, Jamie M. Keck, Christopher A. Eide, Daniel Bottomly, Elie Traer, Jeffrey W. Tyner, Shannon K. McWeeney, Cristina E. Tognon, Brian J. Druker

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)2798-2804
Number of pages7
JournalLeukemia
Volume34
Issue number10
DOIs
StatePublished - Oct 1 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this